COO Cooper Companies Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: COO

Price (delayed)

$73.795

Market cap

$14.39B

P/E Ratio

62.01

Dividend/share

N/A

EPS

$1.19

Enterprise value

$16.71B

?
Relative Growth: Rel. Growth: 42
Relative Strength: Rel. Strength: 50
Relative Valuation: Rel. Valuation: 29
Relative Profitability: Rel. Profitability: 50

The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective ...

Highlights
The company's revenue rose by 6% YoY
Cooper Companies's debt has decreased by 4.8% YoY
The stock's price to earnings (P/E) is 48% more than its last 4 quarters average of 41.2 and 40% more than its 5-year quarterly average of 43.4
The company's net income fell by 43% YoY and by 41% QoQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.coopercos.com
Peers: BSX TFX UTMD NVS

Key stats

What are the main financial stats of COO

COO stock price

How has the Cooper Companies stock price performed over time
Intraday
2.04%
1 week
4.99%
1 month
-0.55%
1 year
4.13%
YTD
-9.96%
QTD
2.91%

Financial performance

How have Cooper Companies's revenue and profit performed over time
Revenue
$4.23B
Gross profit
$2.77B
Operating income
$481.5M
Net income
$235.8M
Gross margin
65.5%
Net margin
5.6%
Cooper Companies's net margin has decreased by 46% YoY and by 42% from the previous quarter
The company's net income fell by 43% YoY and by 41% QoQ
The operating margin has decreased by 39% YoY and by 32% QoQ
The company's operating income fell by 36% YoY and by 31% QoQ

Price vs fundamentals

How does COO's price correlate with its fundamentals

Growth

What is Cooper Companies's growth rate over time

Valuation

What is Cooper Companies stock price valuation
COO P/E details
P/E
62.01
P/B
1.75
P/S
3.4
EV/EBIT
33.06
EV/EBITDA
17.86
EV/Sales
3.95
The stock's price to earnings (P/E) is 48% more than its last 4 quarters average of 41.2 and 40% more than its 5-year quarterly average of 43.4
COO's EPS is down by 43% year-on-year and by 41% since the previous quarter
COO's P/B is 22% below its 5-year quarterly average of 2.2
The price to sales (P/S) is 31% lower than the 5-year quarterly average of 4.8 and 2.1% lower than the last 4 quarters average of 3.4
The company's revenue rose by 6% YoY

Efficiency

How efficient is Cooper Companies business performance
The company's return on equity fell by 45% YoY and by 42% QoQ
Cooper Companies's ROA has decreased by 44% YoY and by 41% from the previous quarter
COO's return on sales is down by 35% year-on-year and by 30% since the previous quarter
COO's return on invested capital is down by 29% year-on-year and by 26% since the previous quarter

Dividends

What is COO's dividend history
Dividend details
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Cooper Companies financials performed over time
Cooper Companies's total assets is 194% more than its total liabilities
The current ratio has decreased by 40% YoY and by 5% from the previous quarter
The company's quick ratio fell by 40% YoY and by 9% QoQ
Cooper Companies's debt is 70% less than its equity
Cooper Companies's debt has decreased by 4.8% YoY
Cooper Companies's debt to equity has decreased by 3.2% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.